Amanote Research

Amanote Research

    RegisterSign In

Approvals and Indications of CGRP Antibodies

The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(19)30229-7
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

August 1, 2019

Authors
Russell NicholsHolland C DetkeHans-Peter HundemerSheena K Aurora
Publisher

Elsevier BV


Related search

New Approvals, Indications

Pharmacy Today
2019English

New & Approved: New Approvals, Indications, Formulations

Pharmacy Today
2018English

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Frontiers in Pharmacology
Pharmacology
2019English

Correction To: FDA and EMA Biosimilar Approvals

Journal of General Internal Medicine
Internal Medicine
2019English

Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2013English

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

Approvals Still Slow, but Pipeline Full

Nature
Multidisciplinary
1991English

Modelling Seasonality in Australian Building Approvals

Construction Economics and Building
BuildingAccountingConstructionManagementBusiness
2012English

Orphan Drug Approvals in Europe: Historical Review and Trends

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy